Study of Protein Tyrosine Phosphatase Non-receptor Type 22 (PTPN22) C1858T Polymorphism in Children and Adolescents of Greek Origin With Type 1 Diabetes Mellitus (T1DM)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- • Difference of distribution of PTPN22 C1858T alleles between patients and controls of Greek origin
研究概览
简要总结
The protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene encodes a lymphoid-specific phosphatase (LYP) which is an important downregulatory factor of T cell activation. A PTPN22 polymorphism, C1858T, was found associated with T1DM in different Caucasian populations.
In this observational case-control study, we aimed at confirming the role of PTPN22, C1858T polymorphism in T1DM predisposition in a Greek population.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 3 Years 至 18 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •For the patients
- •Diagnosis of T1DM according to American Diabetes Association (ADA) Criteria as well as according to International Society for Pediatric and Adolescent Diabetes (ISPAD) Guidelines
- •Unrelated male and female subjects
- •1-20 years of age
- •Come from Greece (At least 3 grandparents are Greek)
- •At least one year post onset of T1DM
- •Sign written informed consent
- •Inclusion Criteria:
- •For the controls
- •Unrelated nondiabetic male and female subjects with no family history of T1DM
- •Equal to or greater than 18 years of age
- •Come from Greece (At least 3 grandparents are Greek)
- •Be screened by a questionnaire to ensure the absence of any diagnostic evidence of autoimmune diseases or family history (first- or second-degree relatives) of T1DM
- •Sign written informed consent
排除标准
- •For the patients •Subjects who do not meet the criteria above
- •Exclusion Criteria:
- •For the controls
- •Subjects who do not meet the criteria above
结局指标
主要结局
• Difference of distribution of PTPN22 C1858T alleles between patients and controls of Greek origin
时间窗: 3 years
次要结局
- • The association between PTPN22 C1858T polymorphism among patients and gender(3 years)
- • The association between the PTPN22 C1858T polymorphism among patients and presence of autoantibodies(3 years)
- • The association between PTPN22 C1858T polymorphism among patients and age of onset of type 1 diabetes mellitus (T1DM)(3 years)
研究者
Styliani Giza
MD, MSc, PhD, 4th Department of Pediatrics, Faculty of Medicine, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece
Aristotle University Of Thessaloniki
